State Street’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$129K Hold
189,753
﹤0.01% 3928
2025
Q1
$173K Hold
189,753
﹤0.01% 3860
2024
Q4
$207K Buy
189,753
+12,700
+7% +$13.8K ﹤0.01% 3844
2024
Q3
$134K Hold
177,053
﹤0.01% 3919
2024
Q2
$220K Sell
177,053
-582,742
-77% -$723K ﹤0.01% 3790
2024
Q1
$1.44M Buy
759,795
+76,100
+11% +$144K ﹤0.01% 3381
2023
Q4
$1.8M Sell
683,695
-14,500
-2% -$38.3K ﹤0.01% 3343
2023
Q3
$1.61M Buy
698,195
+46,900
+7% +$108K ﹤0.01% 3413
2023
Q2
$2.38M Buy
651,295
+510,142
+361% +$1.86M ﹤0.01% 3334
2023
Q1
$504K Hold
141,153
﹤0.01% 3745
2022
Q4
$402K Hold
141,153
﹤0.01% 3845
2022
Q3
$315K Sell
141,153
-17,451
-11% -$38.9K ﹤0.01% 3948
2022
Q2
$395K Sell
158,604
-568,419
-78% -$1.42M ﹤0.01% 3930
2022
Q1
$3.55M Sell
727,023
-935,229
-56% -$4.56M ﹤0.01% 3336
2021
Q4
$18.8M Buy
1,662,252
+355,806
+27% +$4.02M ﹤0.01% 2515
2021
Q3
$19M Sell
1,306,446
-163,629
-11% -$2.38M ﹤0.01% 2516
2021
Q2
$17.1M Buy
1,470,075
+99,470
+7% +$1.16M ﹤0.01% 2594
2021
Q1
$16.7M Sell
1,370,605
-20,973
-2% -$256K ﹤0.01% 2474
2020
Q4
$17.4M Buy
1,391,578
+38,313
+3% +$479K ﹤0.01% 2320
2020
Q3
$20.4M Buy
1,353,265
+326,384
+32% +$4.91M ﹤0.01% 2029
2020
Q2
$25.2M Buy
1,026,881
+655,098
+176% +$16.1M ﹤0.01% 1910
2020
Q1
$5.28M Buy
371,783
+38,082
+11% +$540K ﹤0.01% 2599
2019
Q4
$5.3M Buy
333,701
+47,772
+17% +$758K ﹤0.01% 2816
2019
Q3
$2.41M Sell
285,929
-2,457
-0.9% -$20.7K ﹤0.01% 3148
2019
Q2
$2.59M Buy
288,386
+25,808
+10% +$232K ﹤0.01% 3138
2019
Q1
$2.03M Sell
262,578
-11,780
-4% -$91.1K ﹤0.01% 3140
2018
Q4
$1.29M Buy
274,358
+5,377
+2% +$25.3K ﹤0.01% 3263
2018
Q3
$2.43M Buy
268,981
+51,527
+24% +$466K ﹤0.01% 3174
2018
Q2
$2.58M Buy
217,454
+99,444
+84% +$1.18M ﹤0.01% 3155
2018
Q1
$1.66M Buy
+118,010
New +$1.66M ﹤0.01% 3229